Concepts (254)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 11 | 2024 | 355 | 3.530 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 13 | 2023 | 112 | 2.740 |
Why?
|
| Receptors, Dopamine D2 | 8 | 2019 | 82 | 2.620 |
Why?
|
| Amphetamine | 13 | 2023 | 43 | 2.220 |
Why?
|
| Dopamine | 16 | 2023 | 268 | 2.060 |
Why?
|
| Dopamine Uptake Inhibitors | 6 | 2018 | 147 | 1.200 |
Why?
|
| RGS Proteins | 3 | 2017 | 18 | 1.090 |
Why?
|
| Ethanol | 3 | 2019 | 198 | 1.060 |
Why?
|
| Animals | 40 | 2025 | 8578 | 0.980 |
Why?
|
| Rats | 20 | 2025 | 1946 | 0.920 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2025 | 923 | 0.890 |
Why?
|
| Nucleus Accumbens | 5 | 2018 | 121 | 0.840 |
Why?
|
| Receptors, Opioid | 2 | 2022 | 14 | 0.840 |
Why?
|
| Autoreceptors | 2 | 2014 | 9 | 0.800 |
Why?
|
| Central Nervous System Stimulants | 3 | 2015 | 85 | 0.720 |
Why?
|
| Ventral Tegmental Area | 2 | 2019 | 35 | 0.690 |
Why?
|
| Substance-Related Disorders | 1 | 2022 | 140 | 0.680 |
Why?
|
| Protein Kinase C | 2 | 2013 | 43 | 0.670 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 168 | 0.670 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2019 | 4 | 0.610 |
Why?
|
| Endocytosis | 1 | 2019 | 12 | 0.610 |
Why?
|
| Ubiquitination | 1 | 2019 | 16 | 0.610 |
Why?
|
| Receptors, Dopamine D3 | 2 | 2015 | 33 | 0.550 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2017 | 8 | 0.530 |
Why?
|
| Brain | 5 | 2015 | 1031 | 0.510 |
Why?
|
| Motor Activity | 6 | 2015 | 356 | 0.490 |
Why?
|
| Behavior, Animal | 6 | 2016 | 303 | 0.480 |
Why?
|
| Mice | 17 | 2016 | 2720 | 0.460 |
Why?
|
| Prefrontal Cortex | 4 | 2020 | 90 | 0.460 |
Why?
|
| Cell Membrane | 6 | 2019 | 111 | 0.450 |
Why?
|
| Self Administration | 6 | 2024 | 385 | 0.420 |
Why?
|
| Synaptic Vesicles | 2 | 2003 | 8 | 0.410 |
Why?
|
| Cholesterol | 2 | 2023 | 273 | 0.350 |
Why?
|
| Male | 24 | 2025 | 20739 | 0.350 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 781 | 0.320 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 2014 | 28 | 0.310 |
Why?
|
| Signal Transduction | 4 | 2018 | 771 | 0.310 |
Why?
|
| Corpus Striatum | 3 | 2015 | 75 | 0.300 |
Why?
|
| Benzothiepins | 1 | 2008 | 1 | 0.290 |
Why?
|
| Mutation | 3 | 2025 | 532 | 0.290 |
Why?
|
| Sulfonamides | 1 | 2008 | 86 | 0.280 |
Why?
|
| Neostriatum | 1 | 2007 | 29 | 0.260 |
Why?
|
| Stereotyped Behavior | 2 | 2003 | 14 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2018 | 755 | 0.250 |
Why?
|
| Stress, Psychological | 1 | 2008 | 233 | 0.250 |
Why?
|
| Reward | 2 | 2010 | 70 | 0.250 |
Why?
|
| Disulfides | 1 | 2006 | 43 | 0.250 |
Why?
|
| Cyclic AMP | 3 | 2025 | 56 | 0.250 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 43 | 0.240 |
Why?
|
| Moths | 1 | 2005 | 2 | 0.240 |
Why?
|
| Feeding Behavior | 5 | 2025 | 168 | 0.240 |
Why?
|
| Cysteine | 1 | 2006 | 145 | 0.230 |
Why?
|
| Mice, Knockout | 5 | 2015 | 486 | 0.230 |
Why?
|
| Anxiety | 2 | 2025 | 206 | 0.230 |
Why?
|
| Membrane Transport Proteins | 1 | 2005 | 41 | 0.230 |
Why?
|
| Methylphenidate | 1 | 2005 | 39 | 0.220 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 118 | 0.220 |
Why?
|
| GTP-Binding Protein alpha Subunit, Gi2 | 2 | 2016 | 4 | 0.220 |
Why?
|
| RNA, Messenger | 2 | 2017 | 545 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 130 | 0.220 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 118 | 0.210 |
Why?
|
| Mice, Inbred C57BL | 7 | 2016 | 842 | 0.210 |
Why?
|
| Phosphotransferases | 1 | 2003 | 5 | 0.210 |
Why?
|
| Glutamate Decarboxylase | 1 | 2003 | 17 | 0.210 |
Why?
|
| Isoenzymes | 1 | 2003 | 72 | 0.200 |
Why?
|
| Testosterone | 1 | 2003 | 51 | 0.200 |
Why?
|
| Receptors, Nicotinic | 1 | 2024 | 62 | 0.200 |
Why?
|
| Conditioning, Operant | 4 | 2015 | 125 | 0.190 |
Why?
|
| Parkinsonian Disorders | 1 | 2002 | 11 | 0.190 |
Why?
|
| Basal Ganglia | 1 | 2002 | 23 | 0.180 |
Why?
|
| Brain Chemistry | 1 | 2002 | 46 | 0.180 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 110 | 0.180 |
Why?
|
| Depression | 1 | 2025 | 458 | 0.180 |
Why?
|
| Transcription Factors | 1 | 2022 | 192 | 0.170 |
Why?
|
| Biological Transport | 3 | 2006 | 76 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2016 | 264 | 0.170 |
Why?
|
| Cell Line | 4 | 2016 | 476 | 0.170 |
Why?
|
| Opioid Peptides | 1 | 2020 | 14 | 0.160 |
Why?
|
| Enkephalins | 1 | 2020 | 11 | 0.160 |
Why?
|
| Putamen | 1 | 2020 | 28 | 0.160 |
Why?
|
| Synaptic Transmission | 2 | 2024 | 125 | 0.160 |
Why?
|
| Histone Demethylases | 1 | 2020 | 8 | 0.160 |
Why?
|
| Schizosaccharomyces | 1 | 2020 | 5 | 0.160 |
Why?
|
| Receptors, Opioid, mu | 1 | 2020 | 36 | 0.160 |
Why?
|
| Heterochromatin | 1 | 2020 | 12 | 0.160 |
Why?
|
| Analysis of Variance | 3 | 2015 | 508 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 8 | 0.150 |
Why?
|
| RNA Interference | 1 | 2019 | 79 | 0.150 |
Why?
|
| Psychomotor Performance | 3 | 2009 | 116 | 0.150 |
Why?
|
| Protein Transport | 3 | 2016 | 82 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2016 | 38 | 0.150 |
Why?
|
| Receptors, Vasopressin | 1 | 2018 | 6 | 0.140 |
Why?
|
| Receptors, Oxytocin | 1 | 2018 | 8 | 0.140 |
Why?
|
| Kidney | 2 | 2015 | 528 | 0.140 |
Why?
|
| Tritium | 3 | 2015 | 19 | 0.140 |
Why?
|
| Spinal Nerves | 1 | 2018 | 72 | 0.140 |
Why?
|
| Drug Tolerance | 1 | 2017 | 41 | 0.130 |
Why?
|
| Leptin | 2 | 2025 | 75 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2017 | 63 | 0.130 |
Why?
|
| GTP-Binding Proteins | 1 | 2017 | 40 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2018 | 251 | 0.130 |
Why?
|
| Myocardium | 2 | 2015 | 199 | 0.130 |
Why?
|
| Clathrin | 1 | 2016 | 3 | 0.120 |
Why?
|
| Endosomes | 1 | 2016 | 13 | 0.120 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2016 | 35 | 0.120 |
Why?
|
| Cocaine-Related Disorders | 1 | 2017 | 125 | 0.120 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2016 | 8 | 0.120 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2016 | 26 | 0.120 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2016 | 68 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 319 | 0.120 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2016 | 76 | 0.120 |
Why?
|
| Molecular Sequence Data | 2 | 2006 | 389 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2016 | 149 | 0.120 |
Why?
|
| Ketamine | 1 | 2015 | 20 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2015 | 111 | 0.110 |
Why?
|
| Humans | 5 | 2023 | 34562 | 0.110 |
Why?
|
| Presynaptic Terminals | 1 | 2015 | 40 | 0.110 |
Why?
|
| Extracellular Space | 1 | 2014 | 28 | 0.110 |
Why?
|
| Neurons | 2 | 2010 | 491 | 0.110 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 50 | 0.100 |
Why?
|
| Heart | 1 | 2015 | 191 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2013 | 889 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 260 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 526 | 0.100 |
Why?
|
| Synaptosomes | 2 | 2015 | 17 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2012 | 19 | 0.090 |
Why?
|
| Microdialysis | 2 | 2014 | 41 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2016 | 1128 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 279 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2014 | 328 | 0.080 |
Why?
|
| Feedback, Psychological | 1 | 2009 | 6 | 0.080 |
Why?
|
| Microscopy, Interference | 1 | 2009 | 2 | 0.070 |
Why?
|
| Reinforcement Schedule | 1 | 2009 | 103 | 0.070 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2008 | 2 | 0.070 |
Why?
|
| Motivation | 1 | 2009 | 123 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 81 | 0.070 |
Why?
|
| Receptors, Presynaptic | 1 | 2007 | 1 | 0.070 |
Why?
|
| Biotin | 1 | 2007 | 9 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2002 | 575 | 0.070 |
Why?
|
| Telemetry | 1 | 2007 | 30 | 0.060 |
Why?
|
| Dithiothreitol | 1 | 2006 | 8 | 0.060 |
Why?
|
| Mutant Proteins | 1 | 2006 | 15 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 88 | 0.060 |
Why?
|
| Calcium | 1 | 2008 | 343 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2006 | 16 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 259 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2006 | 77 | 0.060 |
Why?
|
| Coca | 1 | 2005 | 1 | 0.060 |
Why?
|
| Larva | 1 | 2005 | 4 | 0.060 |
Why?
|
| Plant Leaves | 1 | 2005 | 6 | 0.060 |
Why?
|
| Artifacts | 1 | 2006 | 47 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2005 | 77 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 204 | 0.060 |
Why?
|
| Drug Resistance | 1 | 2005 | 42 | 0.060 |
Why?
|
| Harmaline | 2 | 2002 | 2 | 0.060 |
Why?
|
| Phenylalanine | 1 | 2005 | 5 | 0.060 |
Why?
|
| Radioligand Assay | 1 | 2005 | 26 | 0.060 |
Why?
|
| Mutagenesis | 1 | 2005 | 35 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 41 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2025 | 23 | 0.060 |
Why?
|
| Haplorhini | 1 | 2005 | 75 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 118 | 0.060 |
Why?
|
| Tongue | 2 | 2002 | 14 | 0.060 |
Why?
|
| Hand Strength | 2 | 2002 | 106 | 0.060 |
Why?
|
| Stereotypic Movement Disorder | 2 | 2003 | 2 | 0.060 |
Why?
|
| Heart Failure | 1 | 2012 | 780 | 0.060 |
Why?
|
| Locomotion | 2 | 2003 | 37 | 0.060 |
Why?
|
| Transfection | 1 | 2005 | 216 | 0.050 |
Why?
|
| Genetics, Behavioral | 1 | 2004 | 3 | 0.050 |
Why?
|
| Electric Stimulation | 2 | 2015 | 139 | 0.050 |
Why?
|
| Cholinergic Agents | 1 | 2024 | 9 | 0.050 |
Why?
|
| Food | 1 | 2004 | 49 | 0.050 |
Why?
|
| Orchiectomy | 1 | 2003 | 14 | 0.050 |
Why?
|
| Scintillation Counting | 1 | 2003 | 3 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2003 | 12 | 0.050 |
Why?
|
| Female | 4 | 2025 | 21531 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2003 | 36 | 0.050 |
Why?
|
| Carbon Radioisotopes | 1 | 2003 | 24 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 75 | 0.050 |
Why?
|
| Head Movements | 1 | 2003 | 15 | 0.050 |
Why?
|
| Swine | 1 | 2003 | 233 | 0.050 |
Why?
|
| Time Factors | 3 | 2015 | 2353 | 0.050 |
Why?
|
| Neurotrophin 3 | 1 | 2002 | 1 | 0.050 |
Why?
|
| Muscle Weakness | 1 | 2002 | 37 | 0.050 |
Why?
|
| Consummatory Behavior | 1 | 2001 | 4 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2001 | 18 | 0.040 |
Why?
|
| Pyridines | 1 | 2001 | 87 | 0.040 |
Why?
|
| Up-Regulation | 1 | 2002 | 204 | 0.040 |
Why?
|
| Rodentia | 1 | 2001 | 10 | 0.040 |
Why?
|
| Neurophysiology | 1 | 2001 | 11 | 0.040 |
Why?
|
| Tremor | 1 | 2001 | 12 | 0.040 |
Why?
|
| Postural Balance | 1 | 2002 | 152 | 0.040 |
Why?
|
| Lentivirus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Amygdala | 1 | 2019 | 64 | 0.040 |
Why?
|
| Glucose | 1 | 2019 | 194 | 0.040 |
Why?
|
| Ligation | 1 | 2018 | 65 | 0.040 |
Why?
|
| Injections, Spinal | 1 | 2018 | 124 | 0.030 |
Why?
|
| Oxytocin | 1 | 2018 | 31 | 0.030 |
Why?
|
| Hyperalgesia | 1 | 2018 | 86 | 0.030 |
Why?
|
| Hippocampus | 1 | 2019 | 225 | 0.030 |
Why?
|
| Benzoxazines | 1 | 2016 | 28 | 0.030 |
Why?
|
| Cyclohexanols | 1 | 2016 | 22 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2016 | 37 | 0.030 |
Why?
|
| Reaction Time | 2 | 2009 | 131 | 0.030 |
Why?
|
| Morpholines | 1 | 2016 | 47 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2016 | 53 | 0.030 |
Why?
|
| Compulsive Behavior | 1 | 2016 | 4 | 0.030 |
Why?
|
| Endocannabinoids | 1 | 2016 | 43 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2016 | 81 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 83 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2018 | 205 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2016 | 47 | 0.030 |
Why?
|
| Piperidines | 1 | 2016 | 141 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 44 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 2015 | 6 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2015 | 10 | 0.030 |
Why?
|
| Dopamine Agents | 1 | 2015 | 21 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 110 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 236 | 0.030 |
Why?
|
| Analgesics | 1 | 2015 | 117 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 255 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2014 | 97 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 185 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 265 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 600 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 400 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 203 | 0.020 |
Why?
|
| Collagen Type III | 1 | 2012 | 9 | 0.020 |
Why?
|
| Catecholamines | 1 | 2012 | 19 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 131 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2012 | 122 | 0.020 |
Why?
|
| Appetite Regulation | 1 | 2010 | 2 | 0.020 |
Why?
|
| Appetite | 1 | 2010 | 24 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 633 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 99 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 56 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 92 | 0.020 |
Why?
|
| DNA | 1 | 2006 | 235 | 0.010 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2004 | 5 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 744 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 101 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 306 | 0.010 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2002 | 1 | 0.010 |
Why?
|
| Muscle Spindles | 1 | 2002 | 4 | 0.010 |
Why?
|
| Proprioception | 1 | 2002 | 6 | 0.010 |
Why?
|
| Hyperkinesis | 1 | 2002 | 8 | 0.010 |
Why?
|
| Discrimination Learning | 1 | 2002 | 20 | 0.010 |
Why?
|
| Afferent Pathways | 1 | 2002 | 42 | 0.010 |
Why?
|
| Motor Skills | 1 | 2001 | 16 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2003 | 385 | 0.010 |
Why?
|
| Oxidopamine | 1 | 2001 | 24 | 0.010 |
Why?
|
| Space Perception | 1 | 2001 | 30 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2001 | 48 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2001 | 47 | 0.010 |
Why?
|